Literature DB >> 21778150

A preliminary analysis of interactions between genotype, retrospective ADHD symptoms, and initial reactions to smoking in a sample of young adults.

L Cinnamon Bidwell1, Melanie E Garrett, F Joseph McClernon, Bernard F Fuemmeler, Redford B Williams, Allison E Ashley-Koch, Scott H Kollins.   

Abstract

INTRODUCTION: Initial reactions to cigarettes predict later regular smoking. Symptoms of attention deficit hyperactivity disorder (ADHD) have also been shown to increase smoking risk and may moderate the relationship between genotype and smoking. We conducted an exploratory study to assess whether ADHD symptoms interact with genetic variation to predict self-reported initial reactions to smoking.
METHODS: Participants were a subsample of 1,900 unrelated individuals with genotype data drawn from the National Longitudinal Study of Adolescent Health (Add Health), a nationally representative sample of adolescents followed from 1995 to 2002. Linear regression was used to examine relationships among self-reported ADHD symptoms, genotype, and self-reported initial reactions to cigarettes (index scores reflecting pleasant and unpleasant reactions).
RESULTS: Polymorphisms in the DRD2 gene, SLC6A4 gene, and among males, the MAOA gene interacted with retrospective reports of ADHD symptoms in predicting pleasant initial reaction to cigarettes. Polymorphisms in the CYP2A6 gene and, among females, the MAOA gene interacted with retrospective reports of ADHD symptoms in predicting unpleasant initial reaction to cigarettes. No main effect for any of these polymorphisms was observed nor were any interactions with DRD4 and DAT genes.
CONCLUSIONS: These findings suggest that genotypes associated with monoamine neurotransmission interact with ADHD symptoms to influence initial reactions to cigarette smoking. Given that an initial pleasant reaction to cigarettes increases risk for lifetime smoking, these results add to a growing body of literature that suggests that ADHD symptoms increase risk for smoking and should be accounted for in genetic studies of smoking.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21778150      PMCID: PMC3265740          DOI: 10.1093/ntr/ntr125

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  25 in total

1.  Sensations from initial exposure to nicotine predicting adolescent smoking in China: a potential measure of vulnerability to nicotine.

Authors:  Xinguang Chen; Alan Stacy; Hong Zheng; Jianguo Shan; Donna Spruijt-Metz; Jennifer Unger; Jie Gong; Peggy Gallaher; Chunhong Liu; Stanley Azen; Sohaila Shakib; Anderson Johnson C Ph D
Journal:  Nicotine Tob Res       Date:  2003-08       Impact factor: 4.244

Review 2.  The genetic basis for smoking behavior: a systematic review and meta-analysis.

Authors:  Marcus Munafò; Taane Clark; Elaine Johnstone; Michael Murphy; Robert Walton
Journal:  Nicotine Tob Res       Date:  2004-08       Impact factor: 4.244

3.  Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence.

Authors:  C Lerman; N E Caporaso; J Audrain; D Main; N R Boyd; P G Shields
Journal:  Mol Psychiatry       Date:  2000-03       Impact factor: 15.992

4.  Genetic influences on nicotine responses.

Authors:  M J Marks; J A Stitzel; A C Collins
Journal:  Pharmacol Biochem Behav       Date:  1989-07       Impact factor: 3.533

5.  The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder.

Authors:  M F Ward; P H Wender; F W Reimherr
Journal:  Am J Psychiatry       Date:  1993-06       Impact factor: 18.112

Review 6.  ADHD and smoking: from genes to brain to behavior.

Authors:  Francis Joseph McClernon; Scott Haden Kollins
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Recollections and repercussions of the first inhaled cigarette.

Authors:  Joseph R DiFranza; Judith A Savageau; Kenneth Fletcher; Judith K Ockene; Nancy A Rigotti; Ann D McNeill; Mardia Coleman; Constance Wood
Journal:  Addict Behav       Date:  2004-02       Impact factor: 3.913

8.  Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD.

Authors:  Brooke S G Molina; William E Pelham
Journal:  J Abnorm Psychol       Date:  2003-08

9.  Interacting effects of genetic predisposition and depression on adolescent smoking progression.

Authors:  Janet Audrain-McGovern; Caryn Lerman; E Paul Wileyto; Daniel Rodriguez; Peter G Shields
Journal:  Am J Psychiatry       Date:  2004-07       Impact factor: 18.112

10.  The reliability and predictive value of adolescents' reports of initial reactions to smoking.

Authors:  Brant W Riedel; Jonathan L Blitstein; Leslie A Robinson; David M Murray; Robert C Klesges
Journal:  Nicotine Tob Res       Date:  2003-08       Impact factor: 4.244

View more
  10 in total

Review 1.  ADHD, altered dopamine neurotransmission, and disrupted reinforcement processes: implications for smoking and nicotine dependence.

Authors:  Scott H Kollins; R Alison Adcock
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-02-18       Impact factor: 5.067

2.  Genetic interaction between two VNTRs in the MAOA gene is associated with the nicotine dependence.

Authors:  Gea Kõks; Ele Prans; Xuan D Ho; Binh H Duy; Ha Dt Tran; Ngoc Bt Ngo; Linh Nn Hoang; Hue Mt Tran; Vivien J Bubb; John P Quinn; Sulev Kõks
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-02

3.  Childhood and current ADHD symptom dimensions are associated with more severe cannabis outcomes in college students.

Authors:  L C Bidwell; E A Henry; E G Willcutt; M K Kinnear; T A Ito
Journal:  Drug Alcohol Depend       Date:  2013-11-25       Impact factor: 4.492

4.  Nicotinic receptor gene variants interact with attention deficient hyperactive disorder symptoms to predict smoking trajectories from early adolescence to adulthood.

Authors:  Chien-Ti Lee; Bernard F Fuemmeler; F Joseph McClernon; Allison Ashley-Koch; Scott H Kollins
Journal:  Addict Behav       Date:  2013-07-01       Impact factor: 3.913

5.  ADHD diagnosis may influence the association between polymorphisms in nicotinic acetylcholine receptor genes and tobacco smoking.

Authors:  Evelise R Polina; Diego L Rovaris; Lucas A de Azeredo; Nina R Mota; Eduardo S Vitola; Katiane L Silva; Paula O Guimarães-da-Silva; Felipe A Picon; Paulo Belmonte-de-Abreu; Luis A Rohde; Eugenio H Grevet; Claiton H D Bau
Journal:  Neuromolecular Med       Date:  2013-12-28       Impact factor: 3.843

6.  Reactions to reduced nicotine content cigarettes in a sample of young adult, low-frequency smokers.

Authors:  Maggie M Sweitzer; Lauren R Pacek; Rachel V Kozink; Erin Locey; Scott H Kollins; Eric C Donny; F Joseph McClernon
Journal:  Psychopharmacology (Berl)       Date:  2021-05-12       Impact factor: 4.415

7.  Novelty Seeking as a Phenotypic Marker of Adolescent Substance Use.

Authors:  L Cinnamon Bidwell; Valerie S Knopik; Janet Audrain-McGovern; Tiffany R Glynn; Nichea S Spillane; Lara A Ray; Nathaniel R Riggs; Casey R Guillot; Raina D Pang; Adam M Leventhal
Journal:  Subst Abuse       Date:  2015-06-17

8.  Effects of methylphenidate in children with attention deficit hyperactivity disorder: a near-infrared spectroscopy study with CANTAB®.

Authors:  Naomi Matsuura; Makoto Ishitobi; Sumiyoshi Arai; Kaori Kawamura; Mizuki Asano; Keisuke Inohara; Tohru Fujioka; Tadamasa Narimoto; Yuji Wada; Michio Hiratani; Hirotaka Kosaka
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2014-12-31       Impact factor: 3.033

Review 9.  Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions.

Authors:  J Yang; M D Li
Journal:  Mol Psychiatry       Date:  2016-05-10       Impact factor: 15.992

10.  Catecholaminergic gene variants: contribution in ADHD and associated comorbid attributes in the eastern Indian probands.

Authors:  Paramita Ghosh; Kanyakumarika Sarkar; Nipa Bhaduri; Anirban Ray; Keka Sarkar; Swagata Sinha; Kanchan Mukhopadhyay
Journal:  Biomed Res Int       Date:  2013-09-19       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.